Alexander Jetter

Should We Use <i>N</i> -Acetyltransferase Type 2 Genotyping To Personalize Isoniazid Doses?

Martina Kinzig‐Schippers, Dorota Tomalik‐Scharte, Alexander Jetter et al. · Antimicrobial Agents and Chemotherapy · 2005 · 198 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Oral supplementation with 25(OH)D3 versus vitamin D3: Effects on 25(OH)D levels, lower extremity function, blood pressure, and markers of innate immunity

Heike A. Bischoff‐Ferrari, Bess Dawson‐Hughes, Elisabeth Stöcklin et al. · Journal of Bone and Mineral Research · 2011 · 194 citations

Life Sciences, Immunology, Nutritional Sciences +13

Toxicokinetics of Acrylamide in Humans after Ingestion of a Defined Dose in a Test Meal to Improve Risk Assessment for Acrylamide Carcinogenicity

Uwe Fuhr, Melanie I. Boettcher, Martina Kinzig‐Schippers et al. · Cancer Epidemiology Biomarkers & Prevention · 2006 · 182 citations

Pharmacy, Pharmacokinetics, Toxicology +13

Impact of CYP2B6 983T&gt;C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patients

Christoph Wyen, Heidy Hendra, M. Vogel et al. · Journal of Antimicrobial Chemotherapy · 2008 · 170 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

Bilberry ingestion improves disease activity in mild to moderate ulcerative colitis — An open pilot study

Luc Biedermann, Jessica Mwinyi, Michael Scharl et al. · Journal of Crohn s and Colitis · 2012 · 150 citations

Medicine, Nutritional Sciences, Pharmacology +16